InvestorsHub Logo
Followers 840
Posts 120475
Boards Moderated 18
Alias Born 09/05/2002

Re: DewDiligence post# 4420

Wednesday, 04/27/2022 4:25:56 PM

Wednesday, April 27, 2022 4:25:56 PM

Post# of 6446
Migraine drug, rimegepant approved by EU with the brand name, Vydura (a/k/a Nurtec ODT in US):

https://finance.yahoo.com/news/pfizer-biohaven-vydura-rimegepant-granted-104500600.html

PFE has the ex-US commercial rights to Vydura from a deal with BHVN struck in Nov 2021 (#msg-166695371). The sales could be large enough to move the needle even for a company as large as PFE.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PFE News